Differences were considered significant when the P -value was <0.05, and highly significant when the P -value was <0.01.
← all excerpts
Blockade of CD82 by a monoclonal antibody potentiates anti-leukemia effects of AraC in vivo.
1
—
—
Differences were considered significant when the P -value was <0.05, and highly significant when the P -value was <0.01.